6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)-3-(oxolan-3-ylmethylamino)pyrazine-2-carbonitrile
C23H20ClN7O — CID 137431057
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)-3-(oxolan-3-ylmethylamino)pyrazine-2-carbonitrile
6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)-3-(oxolan-3-ylmethylamino)pyrazine-2-carbonitrile (PubChem CID 137431057) has the molecular formula C23H20ClN7O and a molecular weight of 445.91 g/mol. Its IUPAC name is 6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)-3-(oxolan-3-ylmethylamino)pyrazine-2-carbonitrile.
Molecular Properties
| Compound Name | 6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)-3-(oxolan-3-ylmethylamino)pyrazine-2-carbonitrile |
|---|---|
| PubChem CID | 137431057 |
| Molecular Formula | C23H20ClN7O |
| Molecular Weight | 445.91 g/mol |
| Exact Mass | 445.14 |
| IUPAC Name | 6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)-3-(oxolan-3-ylmethylamino)pyrazine-2-carbonitrile |
| SMILES | Cn1ccc(-c2nc(NCC3CCOC3)c(C#N)nc2-c2cc(Cl)c3ncccc3c2)n1 |
| InChI | InChI=1S/C23H20ClN7O/c1-31-7-4-18(30-31)22-21(16-9-15-3-2-6-26-20(15)17(24)10-16)28-19(11-25)23(29-22)27-12-14-5-8-32-13-14/h2-4,6-7,9-10,14H,5,8,12-13H2,1H3,(H,27,29) |
| InChIKey | NAYPCGLZKMZRFT-UHFFFAOYSA-N |
| XLogP | 4.07 |
| TPSA | 101.54 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 445.91 |
| LogP ≤ 5 | 4.07 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 137431057 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.